Father and baby son Lilly

Media Releases

View the latest media releases and news stories from Lilly Australia and New Zealand.

Lilly Appoints New Chief Marketing Officer

1 May 2021- Gabbi Mittas has been appointed as Chief Marketing Officer for Lilly's North Asia Pacific Hub (NAPAC), which includes Australia, New Zealand, Korea, Taiwan and Hong Kong.

View Media Release

TRULICITY® (dulaglutide) in combination with insulin is now available on the PBS for Australians with type 2 diabetes

1 March 2021- Eli Lilly Australia is pleased to announce that dulaglutide (TRULICITY®) is now reimbursed under the Pharmaceutical Benefits Scheme (PBS) for concomitant use with insulin for patients with type 2 diabetes (T2D).

View Media Release

Lilly ANZ Appoints Jill Schein as Incoming Senior HR Director

10 February 2021- Jill Schein has been appointed as Incoming Senior HR Director for Lilly’s North Asia Pacific Hub (NAPAC), which includes Australia, New Zealand, Korea, Taiwan, and Hong Kong.

View Media Release

TRULICITY® (dulaglutide) is now indicated in adults with type 2 diabetes to reduce the risk of Major Adverse Cardiovascular Events (MACE) in patients with multiple risk factors for, or established, cardiovascular disease.

12 August 2020 - Eli Lilly Australia welcomes the Therapeutic Goods Administration’s (TGA) acceptance of the expanded label indication for TRULICITY® (dulaglutide).

View Media Release

PP-MG-AU-0121 04/2021